# cfDNA-seq Tech.



## **I. cfDNA Tech.**

**Nanopore**

* **2021 Mol. Cancer** - Nanopore sequencing from liquid biopsy analysis of copy number variations from cell-free DNA of lung cancer patients

## **II. cfDNA Methylation Tech.**

* **TAPS**
  * **2022 NAR -** Whole-genome long-read TAPS deciphers DNA methylation patterns at base resolution using PacBio SMRT sequencing technology
  * **✨**\[cfTAPS] **2021&#x20;**_**Science Advances**_ - Cell-free DNA TAPS provides multimodal information for early cancer detection
  * **✨**\[TAPS] **2019&#x20;**_**Nature Biotech.**_ - Bisulfite-free direct detection of 5-methylcytosine and 5-hydroxymethylcytosine at base resolution
* **MeDIP**
  * _**2022 NCOMMN.**_ - The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors
  * **2020** _**Nat Medicine**_ - Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes
  * **✨**\[cfMeDIP] **2019&#x20;**_**Nature Protocol**_ - Preparation of cfMeDIP-seq libraries for methylome
  * **✨**\[cfMeDIP] _**2018 Nature**_ - Sensitive tumour detection and classification using plasma cell-free DNA methylomes
* **BS**&#x20;
  * **2022 Nature Cancer** - cfDNA methylome profiling for detection and subtyping of small cell lung cancers
  * **2021** _**Nature Biomedical Engineering**_ - Ultrasensitive detection of circulating tumour DNA via deep methylation sequencing aided by machine learning
  * **✨** \[Targeted BS] _**2021 Annals of Oncology**_ - **Grail and CCGA Consortium** - Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set
  * **✨** \[Targeted BS] _**2020 Annals of Oncology**_ - **Grail and CCGA Consortium -** Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
  * \[chips] _**2018 Nature**_ - DNA methylation-based classification of central nervous system tumours
  * \[WGBS] _**2017 Nature Genetics**_ -  Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA
  * \[WGBS] **2013&#x20;**_**PNAS**_ - Noninvasive detection of cancer-associated genome- wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing
* **5Hmc**
  * _**2019 Gut**_ - Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma
  * _**2019 Blood Adv**_ - Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma
  * _**2017 Cell Res**_ - 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers
* **Nanopore**
  * 2022 Genome Biology - Detecting cell‐of‐origin and cancer‐specific methylation features of cell‐free DNA from Nanopore sequencing

### 1. More reading on cfDNAmet-seq

* _**2020 Sci Adv**_ - Reliable tumor detection by whole-genome methylation sequencing of cell-free DNA in cerebrospinal fluid of pediatric medulloblastoma.&#x20;
* _**2019 Clin Chem**_ - Detection of Colorectal Cancer in Circulating Cell-Free DNA by Methylated CpG Tandem Amplification and Sequencing
* _**2017 Genomic Medicine**_ - Empirical comparison of reduced representation bisulfite sequencing and Infinium BeadChip reproducibility and coverage of DNA methylation in humans.
* _**2015 Cell Res**_ - Genome-scale detection of hypermethylated CpG islands in circulating cell-free DNA of hepatocellular carcinoma patients&#x20;
* _**2014 Clin Epigenetics**_ - Genome-wide methylation profiling of the different stages of hepatitis B virus-related hepatocellular carcinoma development in plasma cell-free DNA reveals potential biomarkers for early detection and high-risk monitoring of hepatocellular carcinoma.

### 2. Validation of DNAmet

* \[mqMSP] **2021 PNAS** - Efficient detection and post-surgical monitoring of colon cancer with a multi-marker DNA methylation liquid biopsy
* \[qMSP]**2019  Clin Epigenetics** - Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood
* \[MSRE] **2016 Clin Epigenetics**  - Detection and monitoring of hypermethylated RASSF1A in serum from patients with metastatic breast cancer
* \[qMSP] **2019 Theranostics** - Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA
